U.S. Markets open in 7 hrs 10 mins

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
11.95+0.15 (+1.27%)
At close: 4:00PM EDT
People also watch
FOLDESPRAUPHPTCTOMER
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue152.381152.381152.381
Cost of Revenue---
Gross Profit152.381152.381152.381
Operating Expenses
Research Development69,232.17447,707.22340,086.347
Selling General and Administrative9,889.33515,625.17415,787.126
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-78,969.128-63,180.016-55,721.092
Income from Continuing Operations
Total Other Income/Expenses Net716.234231.37-60.185
Earnings Before Interest and Taxes-78,252.894-62,948.646-55,781.277
Interest Expense---
Income Before Tax-78,252.894-62,948.646-55,781.277
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-78,252.894-62,948.646-55,781.277
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-78,252.894-62,948.646-55,781.277
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-78,252.894-62,948.646-55,781.277